Cardiac Strain in a Swine Model of Regional Hibernating Myocardium: Effects of CoQ10 on Contractile Reserve Following Bypass Surgery

J Cardiovasc Transl Res. 2016 Aug;9(4):368-73. doi: 10.1007/s12265-016-9696-y. Epub 2016 May 16.

Abstract

There is conflicting clinical evidence whether administration of coenzyme Q10 (CoQ10) improves function following coronary artery bypass graft surgery (CABG). Using a swine model of hibernating myocardium, we tested whether daily CoQ10 would improve contractile function by MRI at 4-week post-CABG. Twelve pigs underwent a thoracotomy and had a constrictor placed on the left anterior descending (LAD). At 12 weeks, they underwent off-pump bypass and received daily dietary supplements of either CoQ10 (10 mg/kg/day) or placebo. At 4-week post-CABG, circumferential strain measurements in the hibernating LAD region from placebo and CoQ10 groups were not different and increased to a similar extent with dobutamine (-14.7 ± 0.6 versus -14.8 ± 0.1, respectively (NS)). Post-sacrifice, oxidant stress markers were obtained in the mitochondrial isolates and protein carbonyl in the placebo, and CoQ10 groups were 6.14 ± 0.36 and 5.05 ± 0.32 nmol/mg, respectively (NS). In summary, CoQ10 did not improve contractile reserve or reduce oxidant stress at 4-week post-CABG.

Keywords: Bypass surgery; Chronically ischemic myocardium; Contractile reserve; Hibernating myocardium; MRI; Mitochondria; Oxidant stress.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Biomechanical Phenomena
  • Cardiotonic Agents / pharmacology*
  • Coronary Artery Bypass, Off-Pump*
  • Coronary Artery Disease / drug therapy*
  • Coronary Artery Disease / metabolism
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / surgery*
  • Disease Models, Animal
  • Female
  • Magnetic Resonance Imaging
  • Mitochondria, Heart / metabolism
  • Myocardial Contraction / drug effects*
  • Myocardial Stunning / drug therapy*
  • Myocardial Stunning / metabolism
  • Myocardial Stunning / physiopathology
  • Myocardial Stunning / surgery*
  • Myocardium / metabolism
  • Myocardium / pathology
  • Oxidative Stress
  • Protein Carbonylation
  • Recovery of Function
  • Stress, Mechanical
  • Sus scrofa
  • Time Factors
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / pharmacology

Substances

  • Biomarkers
  • Cardiotonic Agents
  • Ubiquinone
  • coenzyme Q10